Medicine passport

Matzim La 300 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Diltiazem Hydrochloride
Strength
300 mg
Form
Tablet, Extended Release
ATC code
Not stated by the register
Registered in
United States · Actavis Pharma, Inc.
Prescription
Prescription only
NDC
52544-693

Source: NDC Directory · 2026-09-13

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Canada 2 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
TEVA-DILTIAZEM XC300 mg · tablet (extended-release)Prescription onlyTeva Canada Limited02429349
TIAZAC XC300 mg · tablet (extended-release)Prescription onlyBausch Health, Canada Inc.02256762

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-13. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/us/en/medicines/matzim-la-300-mg-tablet-extended-release